Screener / SEC EDGAR /CIK 0001192448 /10-K filed Feb 23, 2026, compared with Feb 25, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Medical Instruments

GLAUKOS Corp GKOS

Compare with peers Embed
Planned sales, announced before they happen

5 trading plans running, 35 Form 144 notices for $91.7M

10-Q, 10-K and Form 144
Plans running now 5 Thomas Burn, Alex Thurman, Joe Gilliam, Tomas Navratil
Plans adopted 18 reported since May 4, 2023 Form 144 notices 35 $91.7M the sellers expected to sell

What GKOS's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Jun 11, 2025 to Jun 30, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Thomas Burn
Chairman and Chief Executive Officer
Adopted 10b5-1 plan Aug 20, 2026 10-Q Oct 28, 2026
What the company wrote
On August 20, 2026 , Thomas Burn s, the Company’s Chairman and Chief Executive Officer , adopted a 10b5-1 trading plan (the Burns Trading Plan). The Burns Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Burns Trading Plan provides for the potential sale of 280,000 shares of the Company’s common stock commencing November 18, 2026. The Burns Trading Plan terminates on the earlier of June 30, 2027 or the date all shares under the plan are sold.
Alex Thurman
Senior Vice President and Chief Financial Officer
Adopted 10b5-1 plan Aug 18, 2026 10-Q Oct 28, 2026
What the company wrote
On August 18, 2026 , Alex Thurman , the Company’s Senior Vice President and Chief Financial Officer , adopted a 10b5-1 trading plan (the Thurman Trading Plan). The Thurman Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Thurman Trading Plan provides for the potential sale of 17,752 shares of the Company’s common stock commencing November 18, 2026. The Thurman Trading Plan terminates on the earlier of March 25, 2027 or the date all shares under the plan are sold.
Joe Gilliam
President and Chief Operating Officer
Adopted 10b5-1 plan Aug 13, 2026 10-Q Oct 28, 2026
What the company wrote
Insider Trading Arrangements On August 13, 2026 , Joe Gilliam , the Company’s President and Chief Operating Officer , adopted a 10b5-1 trading plan (the Gilliam Trading Plan). The Gilliam Trading Plan is intended to satisfy the affirmative defense of R ule 10b5-1(c) under the Exchange Act. The Gilliam Trading Plan provides for the potential sale of 59,890 shares of the Company’s common stock commencing November 12, 2026. The Gilliam Trading Plan terminates on the earlier of April 30, 2027 or the date all shares under the plan are sold.
Tomas Navratil
Chief Development Officer
Adopted 10b5-1 plan Jun 12, 2026 10-Q Jul 29, 2026
What the company wrote
Insider Trading Arrangements On June 12, 2026 , Tomas Navratil , the Company’s Chief Development Officer , adopted a 10b5-1 trading plan (the Navratil Trading Plan). The Navratil Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Navratil Trading Plan provides for the potential sale of 15,657 shares of the Company’s common stock commencing September 16, 2026. The Navratil Trading Plan terminates on the earlier of December 31, 2026 or the date all shares under the plan are sold.
Alex Thurman
Senior Vice President and Chief Financial Officer
Adopted 10b5-1 plan Jun 9, 2026 10-Q Jul 29, 2026
What the company wrote
On June 9, 2026 , Alex Thurman , the Company’s Senior Vice President and Chief Financial Officer , adopted a 10b5-1 trading plan (the Thurman Trading Plan). The Thurman Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Thurman Trading Plan provides for the potential sale of 20,000 shares of the Company’s common stock commencing September 8, 2026. The Thurman Trading Plan terminates on the earlier of December 14, 2026 or the date all shares under the plan are sold.
Tomas Navratil
Chief Development Officer
Adopted 10b5-1 plan Mar 12, 2026 10-Q Apr 30, 2026
What the company wrote
Insider Trading Arrangements On March 12, 2026 , Tomas Navratil , the Company’s Chief Development Officer , adopted a 10b5-1 trading plan (the Navratil Trading Plan). The Navratil Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Navratil Trading Plan provides for the potential sale of 8,125 shares of the Company’s common stock commencing June 16, 2026. The Navratil Trading Plan terminates on the earlier of September 15, 2026 or the date all shares under the plan are sold.
Alex Thurman
Senior Vice President and Chief Financial Officer
Adopted 10b5-1 plan Dec 15, 2025 10-K Feb 23, 2026
What the company wrote
Additionally, on December 15, 2025 , Alex Thurman , the Company’s Senior Vice President and Chief Financial Officer , adopted a 10b5-1 trading plan (the Thurman Trading Plan). The Thurman Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Thurman Trading Plan provides for the potential sale of 68,521 shares of the Company’s common stock commencing March 16, 2026. The Thurman Trading Plan terminates on the earlier of August 14, 2026 or the date all shares under the plan are sold.
Tomas Navratil
Chief Development Officer
Adopted 10b5-1 plan Dec 15, 2025 10-K Feb 23, 2026
What the company wrote
On December 15, 2025 , Tomas Nav ratil , the Company’s Chief Development Officer , adopted a 10b5-1 trading plan (the Navratil Trading Plan). The Navratil Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Navratil Trading Plan provides for the potential sale of 6,125 shares of the Company’s common stock commencing March 16, 2026. The Navratil Trading Plan terminates on the earlier of June 15, 2026 or the date all shares under the plan are sold.
Alex R. Thurman
Senior Vice President and Chief Financial Officer
Adopted 10b5-1 plan Jun 11, 2025 10-Q Aug 4, 2025
What the company wrote
On June 11, 2025, Alex R. Thurman, the Company’s Senior Vice President and Chief Financial Officer, adopted a new 10b5-1 trading plan (the “Thurman Trading Plan”). The Thurman Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act, and provides for the potential sale of 5,000 shares of the Company’s common stock. The Thurman Trading Plan terminates on the earlier of December 12, 2025 or the date all shares are sold.
Joseph E. Gilliam
President and Chief Operating Officer
Adopted 10b5-1 plan Jun 11, 2025 10-Q Aug 4, 2025
What the company wrote
On June 11, 2025, Joseph E. Gilliam, the Company’s President and Chief Operating Officer, adopted a new 10b5-1 trading plan (the “Gilliam Trading Plan”). The Gilliam Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act, and provides for the potential sale of 90,000 shares of the Company’s common stock. The Gilliam Trading Plan terminates on the earlier of June 12, 2026 or the date all shares are sold.
Thomas W. Burns
Chairman and Chief Executive Officer
Adopted 10b5-1 plan Jun 10, 2025 10-Q Aug 4, 2025
What the company wrote
On June 10, 2025, Thomas W. Burns, the Company’s Chairman and Chief Executive Officer, adopted a new 10b5-1 trading plan (the “Burns Trading Plan”). The Burns Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act, and provides for the potential sale of 275,000 shares of the Company’s common stock. The Burns Trading Plan terminates on the earlier of January 23, 2026 or the date all shares are sold.
Tomas Navratil
Chief Development Officer
Adopted 10b5-1 plan Jun 6, 2025 10-Q Aug 4, 2025
What the company wrote
On June 6, 2025, Tomas Navratil, the Company’s Chief Development Officer, adopted a new 10b5-1 trading plan (the “Navratil Trading Plan”). The Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Navratil Trading Plan was subsequently amended on June 12, 2025, prior to the execution of any sales thereunder. The Navratil Trading Plan, as amended, provides for the potential sale of 8,017 shares of the Company’s common stock. The Navratil Trading Plan terminates on the earlier of December 19, 2025 or the date all shares are sold.
Marc A. Stapley
Board of Directors
Adopted 10b5-1 plan Jun 4, 2025 10-Q Aug 4, 2025
What the company wrote
On June 4, 2025, Marc A. Stapley, a member of the Company’s Board of Directors, adopted a new 10b5-1 trading plan (the “Stapley Trading Plan”). The Stapley Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act, and provides for the potential sale of 15,000 shares of the Company’s common stock. The Stapley Trading Plan terminates on the earlier of June 2, 2026 or the date all shares are sold.
Alex Thurman
Senior Vice President and Chief Financial Officer
Adopted 10b5-1 plan Dec 13, 2024 10-K Feb 25, 2025
What the company wrote
Additionally, on December 13, 2024, Alex Thurman, the Company’s Senior Vice President and Chief Financial Officer, adopted a 10b5-1 trading plan (the Thurman Trading Plan). The Thurman Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Thurman Trading Plan provides for the potential sale of 2,752 shares of the Company’s common stock commencing March 21, 2025. The Thurman Trading Plan terminates on the earlier of June 13, 2025 or the date all shares under the plan are sold
Marc A. Stapley
member of the Company’s Board of Directors
Ended plan Nov 18, 2024 10-Q Nov 1, 2023
What the company wrote
​ On August 11, 2023, Marc A. Stapley, a member of the Company’s Board of Directors, adopted a 10b5-1 trading plan (the “Trading Plan”). The Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Trading Plan provides for the potential sale of 35,000 shares of the Company’s common stock commencing November 13, 2023. The Trading Plan terminates on the earlier of November 18, 2024 or the date all shares are sold.
Tomas Navratil
Chief Development Officer
Adopted 10b5-1 plan Nov 12, 2024 10-K Feb 25, 2025
What the company wrote
On November 12, 2024, Tomas Navratil, the Company’s Chief Development Officer, adopted a 10b5-1 trading plan (the Navratil Trading Plan). The Navratil Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Navratil Trading Plan provides for the potential sale of 5,000 shares of the Company’s common stock commencing February 14, 2025. The Navratil Trading Plan terminates on the earlier of May 15, 2025 or the date all shares under the plan are sold.
Gilbert H. Kliman, M.D.
member of the Company’s Board of Directors
Ended 10b5-1 plan Jun 15, 2024 10-Q Aug 2, 2024
What the company wrote
On June 15, 2024, Gilbert H. Kliman, M.D., a member of the Company’s Board of Directors, terminated the 10b5-1 trading plan that he had entered into on March 15, 2024. On June 15, 2024, Dr. Kliman also adopted a new 10b5-1 trading plan (the “Trading Plan”). The Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Trading Plan provides for the potential sale of 10,000 shares of the Company’s common stock commencing September 16, 2024. The Trading Plan terminates on the earlier of May 23, 2025 or the date all shares are sold
Gilbert H. Kliman, M.D.
member of the Company’s Board of Directors
Adopted 10b5-1 plan Mar 15, 2024 10-Q May 3, 2024
Joseph E. Gilliam
Company’s President and Chief Operating Officer
Adopted 10b5-1 plan Mar 4, 2024 10-Q May 3, 2024
Alex R. Thurman
Senior Vice President and Chief Financial Officer
Adopted 10b5-1 plan May 17, 2023 10-Q Aug 2, 2023
What the company wrote
​ On May 17, 2023, Alex R. Thurman, the Company’s Senior Vice President and Chief Financial Officer, adopted a 10b5-1 trading plan (the “Trading Plan”). The Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Trading Plan provides for the potential sale of 7,446 shares of the Company’s common stock commencing August 17, 2023. The Trading Plan terminates on the earlier of May 31, 2024 or the date all shares are sold.
Show the other 12 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Nov 12, 2026 Gilliam Joseph E
Officer
44,917 $11.1M
Nov 4, 2026 Kliman Gilbert H
Director
2,500 $632K
Oct 30, 2026 Navratil Tomas
Officer
44,436 $10.6M
Oct 5, 2026 Navratil Tomas
Officer
1,527 $251K
Sep 25, 2026 Navratil Tomas
Officer
1,615 $249K
Sep 16, 2026 Navratil Tomas
Officer
1,457 $243K
Aug 28, 2026 Navratil Tomas
Officer
13,744 $2.5M
Aug 19, 2026 Kliman Gilbert H
Director
2,500 $475K
Aug 11, 2026 Gilliam Joseph E
Officer
60,000 $10.8M
Aug 7, 2026 Thurman Alex R.
Officer
20,000 $3.6M
Jul 31, 2026 WEN LEANA
Director
525 $88K
Jul 16, 2026 Thurman Alex R.
Officer
10,000 $1.6M
Jul 9, 2026 Thurman Alex R.
Officer
10,000 $1.6M
Jul 6, 2026 Thurman Alex R.
Officer
10,000 $1.5M
Jul 1, 2026 Navratil Tomas
Officer
716 $100K
Jun 16, 2026 Navratil Tomas
Officer
1,537 $201K
May 14, 2026 Kliman Gilbert H
Director
5,000 $704K
May 11, 2026 Kliman Gilbert H
Director
5,000 $675K
May 1, 2026 WEN LEANA
Director
1,700 $247K
May 1, 2026 Gilliam Joseph E
Officer
19,573 $2.8M
Apr 30, 2026 Thurman Alex R.
Officer
10,000 $1.4M
Apr 10, 2026 Navratil Tomas
Officer
2,093 $246K
Mar 25, 2026 Thurman Alex R.
Officer
2,511 $267K
Mar 24, 2026 Thurman Alex R.
Officer
1,521 $160K
Mar 17, 2026 Thurman Alex R.
Officer
625 $62K
Mar 16, 2026 Navratil Tomas
Officer
1,031 $101K
Feb 19, 2026 WEISNER AIMEE S
Director
15,000 $1.8M
Jan 22, 2026 Gilliam Joseph E
Officer
10,498 $1.3M
Jan 22, 2026 Stapley Marc
Director
15,000 $1.9M
Jan 21, 2026 Gilliam Joseph E
Officer
4,502 $561K
Jan 16, 2026 Burns Thomas William
Officer, Director
186,945 $21.5M
Jan 8, 2026 Burns Thomas William
Officer, Director
88,055 $10.1M
Dec 9, 2025 Kliman Gilbert H
Director
5,000 $536K
Nov 25, 2025 Thurman Alex R.
Officer
315 $33K
Nov 18, 2025 Gilliam Joseph E
Officer
19,340 $1.7M
Show the other 27 notices

From the Form 144 XML filed with the SEC, since Nov 18, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/GKOS/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.